Continuum Advisory’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Continuum Advisory’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,350	Closed	-$233K	–	137
2019 Q2	$233K	Sell	1,350 -50	-4%	-$8.65K	0.16%	108
2019 Q1	$235K	Buy	+1,400	New	+$208K	0.18%	115
2018 Q4	–	Sell	-1,400	Closed	-$234K	–	181
2018 Q3	$234K	Buy	+1,400	New	+$202K	0.16%	135

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Continuum Advisory's GWPH Position: Q3 2019 in Review

Continuum Advisory sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q3 2019, closing a stake of 1,350 shares — an estimated $233K sold.

Continuum Advisory first reported a position in GWPH in Q3 2018 and held it in 3 quarters. The position peaked at $235K in Q1 2019. 316 funds tracked by Wall St. Rank hold GWPH as of Q3 2019.

Continuum Advisory reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q3 2019 after selling out during the quarter.
Continuum Advisory sold 1,350 GW Pharmaceuticals Plc American Depositary Shares shares in Q3 2019, an estimated $233K.
Continuum Advisory first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2018 and held it in 3 quarters.
Continuum Advisory's GW Pharmaceuticals Plc American Depositary Shares position peaked at $235K in Q1 2019.
316 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q3 2019.

Based on Continuum Advisory's 13F filing for Q3 2019, filed 18 May 2021.